Adult T-cell Leukemia/lymphoma - 310 Studies Found
Recruiting |
: High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant :
: 2013-09-03 |
Terminated |
: TALL-104 and Gleevec in Chronic Myelogenous Leukemia Patients : Chronic Myelogenous Leukemia : 2006-12-22 :
|
Recruiting |
: Ruxolitinib for Adult T-Cell Leukemia :
|
Recruiting |
: Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma :
|
Completed |
: Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia : Leukemia, Adult T-Cell : 2005-07-07 : Biological: Denileukin diftitox (Ontak) Patients will be treated with Denileukin Diftitox 9 mcg/kg/d int |
Recruiting |
: Hyper-CVAD Plus Nelarabine in Untreated T-ALL/Lymphoblastic Lymphoma :
|
Recruiting |
: A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL :
: 2015-08-05 :
|
Completed |
: Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac :
: 1999-11-03 : Drug: Yttrium-90 radiolabeled anti-Tac antibody |
Completed |
: Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load : Human T-cell Leukemia Virus Type 1 Infection : 2012-01-25 : Drug: Raltegravir Raltegravir 400 mg po bid |
Completed |
: Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma : Lymphoma : 2002-07-08 :
|